Jonas Oldgren

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Oral Anticoagulants

Top Venues

Journal of the American Heart Association

European heart journal

European heart journal. Cardiovascular pharmacotherapy

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Linda S B Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, David Conen, Marielle Kloosterman, Luciana Armaganijan, Stuart J Connolly, Michael D Ezekowitz, Lars Wallentin, Isabelle Johansson, William F McIntyre, Jonas Oldgren, Jeffrey S Healey
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry. European heart journal 45 (26) (2024)
Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, Richard Aarnio, Achol A Bhowmik, Helmi Keskinen, Sanna Laurila, Minna Lahesmaa-Hatting, Laura Pekkarinen, Henrik Isackson, Anna Kaarina Kirjavainen, Jukka Koffert, Kerstin Heurling, Lauri Nummenmaa, Eleuterio Ferrannini, Jonas Oldgren, Jan Oscarsson, Pirjo Nuutila
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study. Diabetes care (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association (2024)
Linda S B Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, David Conen, Marielle Kloosterman, Luciana Armaganijan, Stuart J Connolly, Michael D Ezekowitz, Lars Wallentin, Isabelle Johansson, William F McIntyre, Jonas Oldgren, Jeffrey S Healey
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry. European heart journal 45 (26) (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association 13 (7) (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association 13 (7) (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association 13 (7) (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association 13 (7) (2024)
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association 13 (7) (2024)
Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, Richard Aarnio, Achol A Bhowmik, Helmi Keskinen, Sanna Laurila, Minna Lahesmaa-Hatting, Laura Pekkarinen, Henrik Isackson, Anna Kaarina Kirjavainen, Jukka Koffert, Kerstin Heurling, Lauri Nummenmaa, Eleuterio Ferrannini, Jonas Oldgren, Jan Oscarsson, Pirjo Nuutila
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study. Diabetes care 47 (9) (2024)
Linda S B Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, David Conen, Marielle Kloosterman, Luciana Armaganijan, Stuart J Connolly, Michael D Ezekowitz, Lars Wallentin, Isabelle Johansson, William F McIntyre, Jonas Oldgren, Jeffrey S Healey
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry. European heart journal 45 (26) (2024)
Stefan K James, Robert F Storey, Jonas Oldgren
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure. European heart journal. Cardiovascular pharmacotherapy 10 (2) (2024)
Stefan K James, Robert F Storey, Jonas Oldgren
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure. European heart journal. Cardiovascular pharmacotherapy (2024)
Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander P Benz, John William Eikelboom, Ziad Hijazi, Kim Kultima, Jonas Oldgren, Lars Wallentin, Joachim Burman, null null
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation. Circulation (2024)
Eva Swahn, Sofia Sederholm Lawesson, Joakim Alfredsson, Mats Fredrikson, Oskar Angerås, Olov Duvernoy, Gunnar Engström, Maria J Eriksson, Erika Fagman, Bengt Johansson, Linda S B Johnson, Nina Johnston, Johan Ljungberg, Maria Mannila, Maria Nordendahl, Jonas Oldgren, Elmir Omerovic, Ellen Ostenfeld, Margaretha Persson, Annika Rosengren, Linn Skoglund Larsson, Johan Sundström, Mia Söderberg, Carl Johan Östgren, Karin Leander, Tomas Jernberg
Sex differences in prevalence and characteristics of imaging detected atherosclerosis - a population-based study. European heart journal. Cardiovascular Imaging (2024)
Linda S B Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, David Conen, Marielle Kloosterman, Luciana Armaganijan, Stuart J Connolly, Michael D Ezekowitz, Lars Wallentin, Isabelle Johansson, William F McIntyre, Jonas Oldgren, Jeffrey S Healey
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry. European heart journal (2024)
Alexander P Benz, Ziad Hijazi, Johan Lindbäck, Stuart J Connolly, John William Eikelboom, Peter Kastner, Andre Ziegler, John H Alexander, Christopher B Granger, Renato Deláscio Lopes, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Jonas Oldgren, Signild Åsberg, Ziad Hijazi, Per Kvidal, Maria Bertilsson, Bo Norrving, null null
Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study. Circulation 146 (14) (2022)
Karl Sjölin, Julia Aulin, Lars Wallentin, Niclas Eriksson, Claes Held, Kim Kultima, Jonas Oldgren, Joachim Burman
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation. Journal of the American Heart Association 11 (14) (2022)
Mark A de Belder, John Deanfield, Stefan James, Jonas Oldgren
Is the ESC blowing its own trumpet or should it have a deserved fanfare? The impact and power of registry data. European heart journal. Quality of care & clinical outcomes 8 (8) (2022)
Ziad Hijazi, Alexander P Benz, Johan Lindbäck, John H Alexander, Stuart J Connolly, John William Eikelboom, Christopher B Granger, Peter Kastner, Renato Deláscio Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation. European heart journal (2022)
Diana A Gorog, Ying X Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro, Kurt Huber, Stavros V Konstantinidis, Deirdre A Lane, Francisco Marin, Jonas Oldgren, Tatjana S Potpara, Vanessa Roldan, Andrea Rubboli, Dirk Sibbing, Hung-Fat Tse, Gemma Vilahur, Gregory Y H Lip
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 24 (11) (2022)
Máté Vámos, Jonas Oldgren, Gi-Byoung Nam, Gregory Y H Lip, Hugh Calkins, Jun Zhu, Kwo-Chang Ueng, Ulf Ludwigs, Mattias Wieloch, John Stewart, Stefan H Hohnloser
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. European heart journal. Cardiovascular pharmacotherapy 8 (4) (2022)
Jonas Oldgren, Sanna Laurila, Axel Åkerblom, Aino Latva-Rasku, Eleni Rebelos, Henrik Isackson, Maria Saarenhovi, Olof Eriksson, Kerstin Heurling, Edvin Johansson, Ulrica Wilderäng, Cecilia Karlsson, Russell Esterline, Eleuterio Ferrannini, Jan Oscarsson, Pirjo Nuutila
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study. Diabetes, obesity & metabolism 23 (7) (2021)